The vast majority of our cases (81.6%) were devoid of IL-8 and CXCR2 immunoreactivity rendering IL-8/CXCR2 axis unlikely to conduct CLL pathogenesis or angiogenesis. The gene discussed is CXCR2; the disease is B-cell chronic lymphocytic leukemia.